BRASH syndrome associated with angiotensin receptor blocker and SGLT2 inhibitor
Crossref DOI link: https://doi.org/10.1007/s43678-021-00213-9
Published Online: 2021-10-01
Published Print: 2022-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nagamine, Takahiko https://orcid.org/0000-0002-0690-6271
Text and Data Mining valid from 2021-10-01
Version of Record valid from 2021-10-01
Article History
Received: 10 August 2021
Accepted: 23 August 2021
First Online: 1 October 2021
Declarations
:
: The author declares no conflict of interest.